![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 32, 29948-29953, August 8, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
¶



From the
Department of Human Genetics, Mount Sinai
School of Medicine, New York, New York 10029, the
Department of Bioscience and Biotechnology,
Kyushu University, Fukuoka 812-8581, Japan, the
||Department of Biochemistry, Hebrew
University-Hadassah School of Medicine, Jerusalem 91120, Israel, and the
**Kekule Institut für Organische Chemie und
Biochemie der Friedrich-Wilhelms Universität, D-53121 Bonn, Germany
An overexpression system was recently developed to produce and purify
recombinant, human acid ceramidase. In addition to ceramide hydrolysis, the
purified enzyme was able to catalyze ceramide synthesis using
[14C]lauric acid and sphingosine as substrates. Herein we report
detailed characterization of this acid ceramidase-associated "reverse
activity" and provide evidence that this reaction occurs in
situ as well as in vitro. The pH optimum of the reverse reaction
was
5.5, as compared with
4.5 for the hydrolysis reaction. Non-ionic
detergents and zinc cations inhibited the activity, whereas most other cations
were stimulatory. Of note, sphingomyelin also was very inhibitory toward this
reaction, whereas the anionic lipids, phosphatidic acid and
phosphatidylserine, were stimulatory. Of various sphingosine stereoisomers
tested in the reverse reaction, only the natural,
D-erythro form could efficiently serve as a substrate.
Using D-erythro-sphingosine and lauric acid as substrates,
the reaction followed normal Michaelis-Menten kinetics. The
Km and Vmax values toward
sphingosine were 23.75 µM and 208.3 pmol/µg/h, respectively,
whereas for lauric acid they were 73.76 µM and 232.5
pmol/µg/h, respectively. Importantly, the reverse activity was reduced in
cell lysates from a Farber disease patient to the same extent as the acid
ceramidase activity. Furthermore, when
12-(N-methyl-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl))
(NBD)-conjugated lauric acid and sphingosine were added to cultured
lymphoblasts from a Farber disease patient in the presence of fumonisin B
(1), the conversion to
NBD-ceramide was reduced
30% when compared with normal cells. These data
provide important new information on human acid ceramidase and further
document its central role in sphingolipid metabolism.
Received for publication, March 31, 2003 , and in revised form, May 14, 2003.
* This work was supported in part by National Institutes of Health Grant R01
DK54830, Grant 6-FY-00-241 from the March of Dimes Birth Defects Foundation,
and Grant 5R03
¶ Supported by a postdoctoral fellowship from the Japan Society for the
Promotion of Science.
This article has been cited by other articles:

To whom correspondence should be addressed: Dept. of Human Genetics, Box 1498,
Mount Sinai School of Medicine, 1425 Madison Ave., Rm. 14-20A, New York, NY
10029. Tel.: 212-659-6711; Fax: 212-849-2447; E-mail:
Edward.Schuchman{at}mssm.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
![]()
![]()

![]()
![]()
![]()
P. Yang, O. Agapova, A. Parker, W. Shannon, P. Pecen, J. Duncan, M. Salvador-Silva, and M. R. Hernandez
DNA microarray analysis of gene expression in human optic nerve head astrocytes in response to hydrostatic pressure
Physiol Genomics,
April 13, 2004;
17(2):
157 - 169.
[Abstract]
[Full Text]
[PDF]
![]()
HOME
HELP
FEEDBACK
SUBSCRIPTIONS
ARCHIVE
SEARCH
TABLE OF CONTENTS
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
All ASBMB Journals
Molecular and Cellular Proteomics
Journal of Lipid Research
ASBMB Today